Showing results (241-250 of 678) with videos related to
Sort By:
Pageof 68
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2014
Pretransplantation fluorine-18-deoxyglucose--positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantationCraig S Sauter, Lauren Lechner, Michael Scordo, et al.International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of ExperienceAndreas Rimner, Shona Lovie, Meier Hsu, et al.Leukemia & Lymphoma|July 16, 2005
R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacyJeffrey L Halaas, Craig H Moskowitz, Steven Horwitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicityBradford S Hoppe, Craig H Moskowitz, Daniel A Filippa, et al.Cancer Journal (Sudbury, Mass.)|November 6, 2002
Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantationDorothy Pan, Craig H Moskowitz, Andrew D Zelenetz, et al.British Journal of Haematology|December 17, 2016
Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab eraSantosha A Vardhana, Craig S Sauter, Matthew J Matasar, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2018
Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to TransplantSantosha Vardhana, Paul A Hamlin, Joanna Yang, et al.Radiology|June 3, 2015
Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive LymphomaGary A Ulaner, Debra A Goldman, Craig S Sauter, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphomaC H Moskowitz, J R Glassman, D Wuest, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2009
Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphomaR Schaffel, C V Hedvat, J Teruya-Feldstein, et al.Pageof 68